For Contemporary Pediatrics, Dr Bobby Lazzara discusses a study published in JAMA Pediatrics that examined how atopic dermatitis impacted the sleep quality and duration of the 14,000 study participants.
Transcript of video:
I’m Dr Bobby Lazzara. Welcome to the Medical News Minute.
Published in JAMA Network, a longitudinal study of almost 14,000 children with atopic dermatitis looking at sleep quality and sleep duration. The participants, well they were followed for a median duration of 11 years. The findings: sleep duration was similar between children with atopic dermatitis (AD) and without AD at all ages. However, children with active AD, well they reported worse sleep quality at all time points studied. Sleep impairment was more common among children with more severe disease and with co-morbid allergic rhinitis or asthma. The take-home message? Sleep quality and interventions to improve it need to be considered in children with atopic dermatitis. Agreed?
I’m Dr. Bobby Lazarra and this is the Medical News Minute.
Lawrence Eichenfield, MD, talks tapinarof cream, 1%, nemolizumab FDA approvals for atopic dermatitis
December 20th 2024"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages."
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.